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Abstract 
Purpose: To develop bone material analogues that can be used in construction of phantoms for 
simultaneous PET/MRI systems. 
 
Methods: Plaster was used as the basis for the bone material analogues tested in this study.  It 
was mixed with varying concentrations of an iodinated CT contrast, a gadolinium-based MR 
contrast agent, and copper sulfate to modulate the attenuation properties and MRI properties (T1 
and T2*).  Attenuation was measured with CT and 68Ge transmission scans, and MRI properties 
were measured with quantitative ultrashort echo time pulse sequences.  A proof-of-concept skull 
was created by plaster casting. 
 
Results: Undoped plaster has a 511 keV attenuation coefficient (~0.14 cm-1) similar to cortical 
bone (0.10-0.15 cm-1), but slightly longer T1 (~500 ms) and T2* (~1.2 ms) MR parameters 
compared to bone (T1 ~ 300 ms, T2* ~ 0.4 ms).  Doping with the iodinated agent resulted in 
increased attenuation with minimal perturbation to the MR parameters.  Doping with a gadolinium 
chelate greatly reduced T1 and T2*, resulting in extremely short T1 values when the target T2* 
values were reached, while the attenuation coefficient was unchanged.  Doping with copper 
sulfate was more selective for T2* shortening and achieved comparable T1 and T2* values to 
bone (after 1 week of drying), while the attenuation coefficient was unchanged. 
 
Conclusions: Plaster doped with copper sulfate is a promising bone material analogue for a 
PET/MRI phantom, mimicking the MR properties (T1 and T2*) and 511 keV attenuation coefficient 
of human cortical bone.  
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Introduction 
Quantitative accuracy in PET/MRI studies is crucial for comparison between scans acquired at 
different times and on different equipment, and it is also an important factor in establishing 
benchmarks for clinical trials1.  One of the major PET/MRI challenges for quantitative PET 
accuracy is to derive the 511 keV attenuation coefficient maps.  In PET/CT systems, the CT 
provides a more direct measure of electron density that has been shown to correlate with PET 
attenuation2, but MRI measures nuclear spin density and properties that do not directly correlate 
with PET attenuation.  Creating MR-derived attenuation maps for PET/MRI is an active area of 
research3–6. 
 
Existing plastic/water-based phantoms do not provide a way of validating the MRI-derived 
attenuation map needed for quantitative PET imaging. A partial solution that has been used is to 
employ template attenuation maps (mu-maps) for standard calibration phantoms (e.g. NEMA IQ) 
to validate PET quantitation.These are however limited to a few geometries, require exact 
alignment with the PET data and do not account for potential errors in mu-maps derived from the 
MRI-based attenuation correction7,8. Furthermore, approaches for generating attenuation maps 
are varied and there is no industry consensus as to which method to use9,10. 
 
Of the different physiological tissues, bone offers a unique challenge because it has little to no 
signal in MRI due to its rapid relaxation rate and low proton density, yet it has the highest 
attenuation for PET photons9. Soft tissues are easier to characterize in MR-derived attenuation 
maps, as they have high signal on MRI and because the driver of differences in attenuation is fat 
versus water content, which is easy to measure with MRI.  Furthermore, there are no prior bone 
phantom materials that satisfy both the PET and MRI properties required, whereas soft-tissue 
analogues with appropriate properties are easier to create from existing MRI phantoms11 and with 
the requirement that the 511 keV attenuation coefficient equal that of water.  Therefore we believe 
that in order to evaluate and validate PET/MRI attenuation correction methodologies in a 
controlled manner, appropriate bone-mineral analogues are needed in order to design 
anthropomorphically accurate body phantoms. 
 
Most currently developed bone material analogues for imaging phantoms target either photon 
attenuation properties or MR properties but not both12,13.  For phantoms mimicking the electron 
density and attenuation, K2PO4 and barium doped thermoplastics and polymer resins have been 
developed14 and a density matched bone-mimicking material is incorporated in the American 
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College of Radiology (ACR) CT accreditation phantom. With respect to MR properties there have 
been very few studies. Prior work has identified a 3D printing material that was MR visible and 
printed bony anatomy, but had a low density13, as well as a resin with MR properties that match 
cortical bone12. 
 
The purpose of this study is to investigate various potential formulations for bone mineral 
analogues using plaster as the baseline material and using precisely varying doping of the 
material to optimize MR relaxation properties and PET attenuation coefficient. 
 
Methods 
 
Materials 
Plaster was used as the basis for the bone material analogues tested in this study. Plaster is a 
cement made by mixing calcium sulfate hemihydrate (CaSO4 · 0.5H2O) with water to form the 
mineral gypsum (CaSO4 · 2H2O). Plaster was chosen as a bone mineral analogue for three main 
reasons. First, plaster has historically been used as an orthopedic bone void filler due to the 
similarity in calcium content, mineral structure, and biomechanical properties of gypsum to 
hydroxyapatite. Second, plaster is facile to construct into a stable anthropomorphic geometry by 
filling a mold or by using a binder jetting 3D-printing process. Finally, it is easy to dope the water 
used in binding the plaster in order to manipulate properties of the material to more accurately 
resemble bone when the material is imaged with MRI and CT. 
 
The water used to form the plaster was doped with three materials, each targeting a separate 
imaging parameter. An iodinated CT contrast, Iohexol (Omnipaque, GE), was used to attempt to 
increase attenuation. A gadolinium-based MR contrast agent, Gadodiamide (Omniscan, GE), was 
used to shorten the MR T1 and T2* relaxation times, as was copper sulfate (CuSO4 · nH2O). Two 
different ranges of concentrations were used for each of the three doping agents, resulting in six 
phantom assemblies. The first three phantoms constructed used the initial “exploratory” ranges, 
and the second set of phantoms constructed used more “targeted” ranges of concentrations 
intended to correspond to the range of physiological variation. Doping concentrations for all 
phantoms are listed in (Table 1). 
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Exploratory Concentrations 
(% by mass) 
Targeted Concentrations 
(% by mass) 
Gd Cu I Gd Cu I 
0.0% 0.0% 0.0% 0.0% 2.0% 0.0% 
0.1% 0.25% 0.25% 0.02% 2.4% 2.4% 
0.2% 0.5% 0.5% 0.04% 2.8% 4.8% 
0.4% 1.0% 1.0% 0.06% 3.2% 7.2% 
0.8% 2.0% 2.0% 0.08% 3.6% 9.6% 
1.6% 4.0% 4.0% 0.1% 4.0% 12.0% 
 
Table 1. Concentrations of the doping agents by mass in both the exploratory and target doping 
ranges 
 
Phantoms were constructed by filling uniform 25 mL cylindrical high-density polyethylene screw-
cap vials with the doped plaster mixtures. The vials were capped before curing of the plaster; care 
was taken to minimize the presence of air bubbles in the vials. Each phantom consisted of 19 
containers arranged in a hexagonal close packing (Fig. 1). Seven containers, including the center 
container, were filled with doped water solutions that ensured sufficient signal for successful MR 
scan calibration. The remaining twelve containers were filled with six different plaster 
concentrations; one of each pair of samples was placed nearer the center of the phantom and 
one was placed near the outside of the phantom to control for possible slow-varying intensity 
inhomogeneities in the images. MR scans of the “exploratory” phantom were acquired four times 
over the course of a month, and once three months after construction, while the ‘targeted’ 
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phantom was scanned three times over the course of a month. CT and 68Ge transmission scans 
were acquired once for each phantom after all MR scans had been acquired. 
 
 
Figure 1. The testing phantom design consisted of polyethylene vials filled with doped or 
undoped plaster as well as vials filled with water for calibration.  (a) Photograph of the vial 
assembly for testing. Examples of (b) 68Ge Transmission scan of iodine-doped vials (c) 
UTE image at TE = 24 microseconds and (d) later TE image of copper sulfate-doped vials. 
 
Imaging 
Quantitative MR parameter mapping was performed on a 3T GE MR750 scanner (GE Healthcare, 
Waukesha, WI). All scans for MR quantification used a 3D gradient echo sequence with ultrashort 
echo times (UTE) and radial readouts in order to maximize signal from the plaster (Fig. 1). A 
single-channel quadrature head coil was used to provide more uniform B1 homogeneity. T1 
quantification used a variable flip angle (VFA) approach15,16 with flip angles of 8 and 44 degrees; 
a b 
c d 
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the TE for these scans was 24 microseconds, with a TR of 6.4 milliseconds. T2* quantification 
was performed using a multi-echo sequence with 32 echo times ranging from 24 microseconds 
to 5 milliseconds17; these scans used an 8 degree flip angle and a TR of 9.276 milliseconds. The 
reconstructed images were 256x256 with 108 slices and 2mm isotropic voxels. 
 
68Ge transmission scans were acquired on a Siemens HR+ scanner. This scanner is equipped 
with 3 rotating 68Ge lines source (approximately 70MBq each), and 45 minutes transmission 
scans were performed for each arrangement of 19 containers.. These data provided direct 
quantitative measurement of the 511 keV photon attenuation coefficients of the different plaster 
formulations. CT scans were also acquired on a  Siemens Sensation Open CT scanner, using a 
cyberknife radiation treatment planning protocol for the head with a 120 kVp beam for initial 
estimations of attenuation (data not shown). 
 
Image processing and analysis 
Cylindrical regions of interest (ROIs) were placed in the center of each container with a radius 
half that of the container and a length half the container length as well. This was done to minimize 
the possibility of partial voluming from the container walls and possible air bubbles, and to 
minimize boundary effects. T1 was calculated using the following equation (VFA method) 
 
T1 = -TR / ln((S1/sin(a1) - S2/sin(a2))/(S1/tan(a1) - S2/tan(a2)))    (1) 
 
where TR is the repetition time of the UTE sequence, a1 and a2 are the two flip angles used (8 
and 4 degrees, respectively), and S1 and S2 are the corresponding signal magnitudes. An example 
of the implementation of this method for our data is illustrated in (Fig. 2). 
 
T2* was calculated by pooling the voxels within the ROI and fitting the noise-corrected power of 
the complex UTE signal 
 
Pcorr = P0 exp(-2TE/T2*)         (2) 
 
Where 𝑃𝑃𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 = 𝑆𝑆2 − 2𝜎𝜎2 with 𝑆𝑆2 being the square of the observed signal and 2𝜎𝜎2 being the noise 
estimate that can be computed as the mean power in an ROI devoid of signal. This power fitting 
avoids bias due to non-zero mean noise in the MRI magnitude18. Since we know that the plaster 
signal decay is rapid we used the mean signal in a plaster ROI on the last echo to estimate the 
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noise. Fitting the model was performed using the SciPy implementation of the Levenberg-
Marquardt algorithm for non-linear least squares estimation. An example of this fit for our data is 
illustrated in (Fig. 2). 
 
 
Figure 2. Sample data fitting. (left) T2* was quantified based on multiTE MRI and was fit to the 
noise-corrected power of the MR signal. (right) T1 was quantified using a variable flip angle 
method. 
 
 
CT attenuation values measured in Hounsfield units were averaged over the matching ROI on 
the CT images. 511 keV photon attenuation values derived from the 68Ge transmission scans 
were averaged over an ROI of approximately the same size in approximately the same position. 
 
 
Results 
We targeted MR relaxation parameter values of T1 between 200 and 250 ms19–21 and T2* between 
300 and 500 us19–22, as well as a 511 keV attenuation coefficient between 0.10 and 0.15 cm-1.  
The results of the T2*, T1, and attenuation coefficients are show in Figures 3, 4, and 5, 
respectively, and the targeted parameter ranges are highlighted as well.  
 
Undoped plaster had a measured T1 of between 250 and 820 ms, measured T2* of between 1070 
and 1330 microseconds, and measured 511 keV attenuation coefficients between 0.140 cm-1 and 
0.148 cm-1. 
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Figure 3. T2* results. The doped plaster R2* relaxivity was measured within one day after 
mixing as well as several later times after preparation. Each point represents an individual vial 
(two vials were prepared for each concentration), and the dashed lines show linear fits to the 
R2* versus concentration. The gray shaded area indicates our targeted T2* range for dense 
bone of 300 to 500 microseconds which is based on reference [19-22].  The top row is from the 
Exploratory Concentrations, and the bottom row from the Targeted Concentrations. 
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Figure 4. T1 results. The doped plaster R1 relaxivity was measured within one day after mixing 
as well as several later times after preparation. Each point represents an individual vial (two 
vials were prepared for each concentration), and the dashed lines show linear fits to the R1 
versus concentration. The gray shaded area indicates our targeted T1 range for dense bone of 
200 to 250 milliseconds which is based on reference [19-21].  The top row is from the 
Exploratory Concentrations, and the bottom row from the Targeted Concentrations. 
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Figure 5. 511 keV photon attenuation results. The doped plaster samples 511 keV photon 
attenuation was measured a 68Ge transmission scan. The open circles show the values for the 
“exploratory” mixtures, while the closed circles are the values for the “target” mixtures. The gray 
shaded area indicates our targeted attenuation range for dense bone of 0.10 to 0.15 cm-1. 
 
Exploratory phantoms 
Doping with gadolinium causes significant shortening of T1. Doping plaster with gadodiamide 
causes T1 to shorten to between 4 and 90 ms. The T1 shortening increases with greater quantities 
of gadodiamide doping as we would expect. The R1 relaxivity was relatively stable for the scans 
up to Day 19 after mixture preparation. It was larger at the Day 117 scan, though the residuals 
are large for the linear fit, especially for containers with a large amount of gadodiamide doping. 
 
Gadodiamide doped samples had a measured T2* of between 210 microseconds and 1180 
microseconds. T2* shortening increase with greater quantities of gadodiamide doping. Relaxivity 
appears fairly stable across measurements taken in the first month, with the final Day 117 
measurement seeming to indicate a reduced R2* relaxivity effect. 
 
Gadolinium doping across the broad range of concentrations in the exploratory phantom does not 
appear to significantly impact the attenuation of 511 keV photons in plaster. 
 
Doping with copper sulfate causes a strong shortening of T1 with increasing concentration of 
copper sulfate shortly after mixing. However, this prominent initial effect dissipates in 
measurements taken more than six days after the construction of the phantom. On the day the 
phantom was constructed T1 values vary between 5 and 600 milliseconds, however, after one 
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week copper sulfate-doped phantoms have a measured  T1 of between 300 and 800 milliseconds, 
with no obvious relationship with the copper sulfate concentration. 
 
Copper sulfate doping significantly shortens T2*. Values for samples doped with copper sulfate 
range from 230 microseconds to 1140 microseconds. T2* tends to decrease with increasing 
copper sulfate doping and the observed R2* relaxivity was relatively stable over time. 
 
The amount of copper sulfate doping does not appear to significantly impact the attenuation of 
511 keV photons in plaster over this broad range of concentrations. 
 
Iohexol doping in this exploratory range of concentrations does not appear to have any significant 
effect on T1 or T2* relaxation times. Values of T1 and T2* do not differ significantly between doped 
and undoped samples. Across this range of quantities of iohexol doping the 511 keV photon 
attenuation values also appear to cluster around the value for undoped plaster. 
 
Targeted concentration phantoms 
Gadodiamide doping still has a strong effect on T1 shortening across the physiologically targeted 
range of concentrations . Gadodiamide-doped samples had T1 values ranging from 30 to 200 
milliseconds. T1 shortening increases linearly even across this narrow range of concentrations. 
The relaxivity is moderately stable over the course of a month, though the effect increases slightly 
with time. 
 
At these small concentrations the effect of gadodiamide doping on T2* is negligible. T2* values for 
doped samples range from 1100 to 1460 microseconds, with a slight shortening of T2* with 
increasing gadodiamide concentration. This relatively small effect is consistent across all time 
points. 
 
Attenuation values for 511 keV photons over this range of gadodiamide quantities clusters very 
closely around the value for undoped plaster. 
 
Copper sulfate doping between 2% and 4% by mass causes significant T1 shortening immediately 
after the sample is mixed, though the effect goes away when measured one week later. The initial 
T2* values were measured between 4 and 6 milliseconds, however after one week T1 values are 
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measured between 220 and 480 milliseconds, which is in the same range of values for undoped 
plaster. 
 
There is a fairly strong reliable linear effect of copper sulfate doping on T2* within this targeted 
range of concentrations. T2* values range between 320 and 620 microseconds. The relaxivity is 
fairly consistent between the measurements taken one week and three weeks after the samples 
were mixed, while initially the relaxivity appeared slightly elevated. 
 
511 keV photon attenuation at these concentrations of copper sulfate doping appear slightly 
elevated relative to the attenuation coefficient of undoped plaster. Copper sulfate-doped samples 
have attenuation coefficients ranging between 0.145 cm-1 and 0.152 cm-1, while undoped plaster 
attenuation coefficients range between 0.140 cm-1 and 0.148 cm-1 
 
With a high enough concentration of iohexol doping we were able to observe a shortening of T1. 
Iohexol-doped samples had T1 values ranging from 340 to 720 milliseconds with shorter values 
observed for higher quantities of doping. The linear effect was preserved consistently across all 
time points. 
 
At these high iohexol concentrations a slight shortening of T2* was also observed. Measured T2* 
values ranged between 900 and 1460 microseconds. These values are still fairly close to the T2* 
value for undoped plaster, but there is a slight linear effect of iohexol concentration on T2* that 
remains consistent across the three time points surveyed. 
 
Iohexol doping does appear to significantly increase the attenuation of doped plaster to 511 keV 
photons. Attenuation coefficients of doped samples range from 0.144 to 0.162 cm-1. 
 
Discussion 
Comparing doped material properties to physiological values for bone 
Previous studies have measured physiological values for cortical bone of T1 between 200 and 
250 milliseconds, T2* between 300 and 500 microseconds, and 511 keV attenuation coefficients 
between 0.10 cm-1 and 0.15 cm-1. Based on our measurements of undoped plaster, we targeted 
doping to decrease T1 and T2* while maintaining the attenuation coefficient. 
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Gadolinium exhibits such a strong T1 shortening effect that it effectively overshoots the target T1 
values taken from the literature for bone at both high and low concentrations, however, given that 
the relaxivity is linear it is probable that smaller concentrations, less than 0.02% by mass, would 
fall within the range of physiological T1 values for bone (between 200 and 250 milliseconds). At 
the concentrations required to fit this range gadodiamide would not be expected to significantly 
impact the T2* or attenuation coefficient of the material. 
 
Copper sulfate, on the other hand, has a strong effect on T2*, and after one week of drying it had 
almost no effect on T1. The most likely explanation for this is that as the plaster dries the copper 
sulfate is in less proximity to the bound water, mitigating T1 effects, while the T2* effect, which is 
likely related to increased magnetic susceptibility, is still active over the larger distances between 
Cu ions and bound water molecules in the hydrated crystal. Doping values of between 2.8% and 
4% by mass give T2* values that fall within the physiological range of T2* values (between 300 and 
500 microseconds) with observed stability over time. Stability could potentially be increased by 
sealing the plaster with a waterproof coating, like polyurethane rubber, at some specified point 
after the material has been mixed, to prevent further loss of water once the MR relaxation 
properties are within the desired range.  
 
Concentrations of copper sulfate above 3% by mass may have the unwanted effect of increasing 
the attenuation coefficient for 511 keV photons beyond the physiological range. Typical 
attenuation coefficients for bone range between 0.10 cm-1 and 0.15 cm-1. Because plaster is 
significantly dense on its own, undoped plaster is already at the high part of this range. Doping 
with excessive concentrations of copper sulfate could cause the attenuation coefficient to 
marginally exceed physiologically typical values. 
 
Iohexol can be used to increase the attenuation coefficient if needed without significantly 
impacting the MR relaxation properties of the material. However, iohexol concentrations in excess 
of approximately 7% by mass might also cause an excessive increase in the attenuation 
coefficient that would exceed the physiological range. 
 
Based on our results, doped plaster can be directly used for simulating dense bone based on the 
measured attenuation coefficient for 511 keV photons. Alternate mixing formulations may allow 
for simulating less dense bone. For example, mixing doped plaster with oil could provide a good 
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simulation of trabecular bone and bone marrow, or mixing such that more air is trapped in the 
plaster could simulate less dense bone. 
 
Casting plaster in anthropomorphic geometries 
As a proof of concept for an anthropomorphic phantom we used matrix casting to build phantoms 
from undoped and copper sulfate-dopte plaster in the shape of the posterior half of a skull (Fig. 
6). We generated posterior skull molds from 3D-printed PLA plastic prototypes using silicone 
rubber and filled them with undoped plaster and plaster doped with 3% by weight copper sulfate, 
as the T2* of plaster at this concentration of copper sulfate doping fell within the physiological 
range. Plaster doped with 3% copper sulfate proved difficult to pour to fill the mold as the plaster 
solidified much more quickly than undoped plaster, the resulting cast had a rough surface and 
inconsistent thickness. 
 
In a first experiment, we created and compared a first set of doped and undoped casts scanned 
with the T2* quantification protocol.  We observed a shortening of T2* for the doped plaster cast 
relative to the undoped cast, however, the extent of the effect was not what we had observed in 
containers. The casts were scanned within a week of construction.  After the casts had initially 
set they were left in open air, potentially leading to different drying characteristics than that of 
plaster sealed in small vials. 
 
 
Figure 6. Proof of concept anthropomorphic skull cast using plaster.  A 3D-printed PLA skull 
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was used to create a silicone mold from which a plaster cast was created.  In Experiment 
#1, an undoped and a copper sulfate doped (3.0 %wt CuSO4) plaster cast of the posterior 
skull half were compared.  In Experiment #2, an undoped plaster cast of the posterior skull 
half and the original PLA printed anterior skull half were imaged. 
 
In a second experiment, we created a second undoped plaster cast and also imaged the PLA 
plastic prototype.  In the plaster we observed an increase in microbubbles on high resolution CT. 
We also observed T2* values shorter than undoped plaster in vials and our first undoped plaster 
cast that were actually within the physiologic range for bone for this plaster phantom.  We 
speculate the increased microbubbles shortened the T2* due to local magnetic susceptibility 
differences.  
 
The T2* of PLA plastic was also quantified in this experiment, with values close to those for 
undoped plaster in previous experiments.  However, the CT attenuation for PLA plastic (~ 300 
HU, Fig. 6) is significantly less than that of plaster (~ 750 HU, Fig. 6) and of bone (500-2000 HU). 
 
3D-printed materials for finite deposition modeling printers tend to be thermoplastics with low 
photon attenuation, and often low MR signal if any. This is similar for resins used in 
stereolithography 3D printing. Plaster can be used as the material for some binder jetting process-
based 3D printers, though such printers and plaster-based materials are rare and tend to be 
proprietary. Furthermore the binder jetting process for producing 3D printed plaster tends to 
reduce the density of the final part relative to cast parts. Casting undoped plaster in a mold can 
be an effective way to produce a phantom with an anthropomorphic geometry with accurate MR 
and PET attenuation properties. 
 
Conclusion 
Gadodiamide doping of plaster caused T2* shortening at high concentrations, with significant T1 
shortening even at low concentrations. Copper sulfate doping of plaster caused significant T2* 
shortening at moderate to high concentrations. Copper sulfate doping initially causes T1 
shortening but that effect fades over time, presumably as the material dries. Iohexol doping of 
plaster has some effect on MR relaxation, causing minor shortening of both T1 and T2* at high 
concentrations, although the effect is potentially small enough to be negligible. Iohexol, however, 
does increase attenuation of the material for 511 keV photons.  Plaster with these doping agents 
is very promising to create a bone-analogous material that is quantitatively bone-like for both MR 
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relaxation and PET attenuation properties so could be used to evaluate PET/MRI attenuation 
correction methods. 
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